Global Transdermal Patch Market Insights and Forecast to 2027
Table of Contents1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type
1.4.2 Methyl Salicylate-based Patch
1.4.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Sales Estimates and Forecasts 2016-2027
2.2 Global Transdermal Patch Revenue Estimates and Forecasts 2016-2027
2.3 Global Transdermal Patch Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Transdermal Patch Regions by Sales
2.4.1 Global Top Transdermal Patch Regions by Sales (2016-2021)
2.4.2 Global Top Transdermal Patch Regions by Sales (2022-2027)
2.5 Global Top Transdermal Patch Regions by Revenue
2.5.1 Global Top Transdermal Patch Regions by Revenue (2016-2021)
2.5.2 Global Top Transdermal Patch Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Transdermal Patch Sales by Manufacturers
3.1.1 Global Top Transdermal Patch Manufacturers by Sales (2016-2021)
3.1.2 Global Top Transdermal Patch Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Transdermal Patch Sales in 2020
3.2 Global Transdermal Patch Revenue by Manufacturers
3.2.1 Global Top Transdermal Patch Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Transdermal Patch Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal Patch Revenue in 2020
3.3 Global Transdermal Patch Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Transdermal Patch Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal Patch Sales by Type
4.1.1 Global Transdermal Patch Historical Sales by Type (2016-2021)
4.1.2 Global Transdermal Patch Forecasted Sales by Type (2022-2027)
4.1.3 Global Transdermal Patch Sales Market Share by Type (2016-2027)
4.2 Global Transdermal Patch Revenue by Type
4.2.1 Global Transdermal Patch Historical Revenue by Type (2016-2021)
4.2.2 Global Transdermal Patch Forecasted Revenue by Type (2022-2027)
4.2.3 Global Transdermal Patch Revenue Market Share by Type (2016-2027)
4.3 Global Transdermal Patch Price by Type
4.3.1 Global Transdermal Patch Price by Type (2016-2021)
4.3.2 Global Transdermal Patch Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Transdermal Patch Sales by Application
5.1.1 Global Transdermal Patch Historical Sales by Application (2016-2021)
5.1.2 Global Transdermal Patch Forecasted Sales by Application (2022-2027)
5.1.3 Global Transdermal Patch Sales Market Share by Application (2016-2027)
5.2 Global Transdermal Patch Revenue by Application
5.2.1 Global Transdermal Patch Historical Revenue by Application (2016-2021)
5.2.2 Global Transdermal Patch Forecasted Revenue by Application (2022-2027)
5.2.3 Global Transdermal Patch Revenue Market Share by Application (2016-2027)
5.3 Global Transdermal Patch Price by Application
5.3.1 Global Transdermal Patch Price by Application (2016-2021)
5.3.2 Global Transdermal Patch Price Forecast by Application (2022-2027)
6 North America
6.1 North America Transdermal Patch Market Size by Type
6.1.1 North America Transdermal Patch Sales by Type (2016-2027)
6.1.2 North America Transdermal Patch Revenue by Type (2016-2027)
6.2 North America Transdermal Patch Market Size by Application
6.2.1 North America Transdermal Patch Sales by Application (2016-2027)
6.2.2 North America Transdermal Patch Revenue by Application (2016-2027)
6.3 North America Transdermal Patch Market Size by Country
6.3.1 North America Transdermal Patch Sales by Country (2016-2027)
6.3.2 North America Transdermal Patch Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Transdermal Patch Market Size by Type
7.1.1 Europe Transdermal Patch Sales by Type (2017-2027)
7.1.2 Europe Transdermal Patch Revenue by Type (2017-2027)
7.2 Europe Transdermal Patch Market Size by Application
7.2.1 Europe Transdermal Patch Sales by Application (2017-2027)
7.2.2 Europe Transdermal Patch Revenue by Application (2017-2027)
7.3 Europe Transdermal Patch Market Size by Country
7.3.1 Europe Transdermal Patch Sales by Country (2017-2027)
7.3.2 Europe Transdermal Patch Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transdermal Patch Market Size by Type
8.1.1 Asia Pacific Transdermal Patch Sales by Type (2018-2027)
8.1.2 Asia Pacific Transdermal Patch Revenue by Type (2018-2027)
8.2 Asia Pacific Transdermal Patch Market Size by Application
8.2.1 Asia Pacific Transdermal Patch Sales by Application (2018-2027)
8.2.2 Asia Pacific Transdermal Patch Revenue by Application (2018-2027)
8.3 Asia Pacific Transdermal Patch Market Size by Region
8.3.1 Asia Pacific Transdermal Patch Sales by Region (2018-2027)
8.3.2 Asia Pacific Transdermal Patch Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Transdermal Patch Market Size by Type
9.1.1 Latin America Transdermal Patch Sales by Type (2019-2027)
9.1.2 Latin America Transdermal Patch Revenue by Type (2019-2027)
9.2 Latin America Transdermal Patch Market Size by Application
9.2.1 Latin America Transdermal Patch Sales by Application (2019-2027)
9.2.2 Latin America Transdermal Patch Revenue by Application (2019-2027)
9.3 Latin America Transdermal Patch Market Size by Country
9.3.1 Latin America Transdermal Patch Sales by Country (2019-2027)
9.3.2 Latin America Transdermal Patch Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Transdermal Patch Market Size by Type
6.1.1 Middle East and Africa Transdermal Patch Sales by Type (2016-2027)
6.1.2 Middle East and Africa Transdermal Patch Revenue by Type (2016-2027)
6.2 Middle East and Africa Transdermal Patch Market Size by Application
6.2.1 Middle East and Africa Transdermal Patch Sales by Application (2016-2027)
6.2.2 Middle East and Africa Transdermal Patch Revenue by Application (2016-2027)
6.3 Middle East and Africa Transdermal Patch Market Size by Country
6.3.1 Middle East and Africa Transdermal Patch Sales by Country (2016-2027)
6.3.2 Middle East and Africa Transdermal Patch Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Description
11.1.5 Hisamitsu Pharmaceutical Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Johnson & Johnson Transdermal Patch Product Description
11.2.5 Johnson & Johnson Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Novartis Transdermal Patch Product Description
11.3.5 Novartis Related Developments
11.4 UCB Pharma
11.4.1 UCB Pharma Corporation Information
11.4.2 UCB Pharma Overview
11.4.3 UCB Pharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 UCB Pharma Transdermal Patch Product Description
11.4.5 UCB Pharma Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Mylan Transdermal Patch Product Description
11.5.5 Mylan Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Overview
11.6.3 Teva Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Teva Pharmaceutical Transdermal Patch Product Description
11.6.5 Teva Pharmaceutical Related Developments
11.7 Nitto Denko
11.7.1 Nitto Denko Corporation Information
11.7.2 Nitto Denko Overview
11.7.3 Nitto Denko Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Nitto Denko Transdermal Patch Product Description
11.7.5 Nitto Denko Related Developments
11.8 Grünenthal
11.8.1 Grünenthal Corporation Information
11.8.2 Grünenthal Overview
11.8.3 Grünenthal Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Grünenthal Transdermal Patch Product Description
11.8.5 Grünenthal Related Developments
11.9 IBSA Group
11.9.1 IBSA Group Corporation Information
11.9.2 IBSA Group Overview
11.9.3 IBSA Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 IBSA Group Transdermal Patch Product Description
11.9.5 IBSA Group Related Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Overview
11.10.3 GSK Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 GSK Transdermal Patch Product Description
11.10.5 GSK Related Developments
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Description
11.1.5 Hisamitsu Pharmaceutical Related Developments
11.12 Pfizer
11.12.1 Pfizer Corporation Information
11.12.2 Pfizer Overview
11.12.3 Pfizer Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Pfizer Product Description
11.12.5 Pfizer Related Developments
11.13 Chattem
11.13.1 Chattem Corporation Information
11.13.2 Chattem Overview
11.13.3 Chattem Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Chattem Product Description
11.13.5 Chattem Related Developments
11.14 Dr Reddy's Laboratories
11.14.1 Dr Reddy's Laboratories Corporation Information
11.14.2 Dr Reddy's Laboratories Overview
11.14.3 Dr Reddy's Laboratories Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Dr Reddy's Laboratories Product Description
11.14.5 Dr Reddy's Laboratories Related Developments
11.15 Bayer
11.15.1 Bayer Corporation Information
11.15.2 Bayer Overview
11.15.3 Bayer Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Bayer Product Description
11.15.5 Bayer Related Developments
11.16 Mundipharma
11.16.1 Mundipharma Corporation Information
11.16.2 Mundipharma Overview
11.16.3 Mundipharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Mundipharma Product Description
11.16.5 Mundipharma Related Developments
11.17 Endo International
11.17.1 Endo International Corporation Information
11.17.2 Endo International Overview
11.17.3 Endo International Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Endo International Product Description
11.17.5 Endo International Related Developments
11.18 Beijing Tide Pharmaceutical
11.18.1 Beijing Tide Pharmaceutical Corporation Information
11.18.2 Beijing Tide Pharmaceutical Overview
11.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2016-2021)
11.18.4 Beijing Tide Pharmaceutical Product Description
11.18.5 Beijing Tide Pharmaceutical Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Transdermal Patch Value Chain Analysis
12.2 Transdermal Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Patch Production Mode & Process
12.4 Transdermal Patch Sales and Marketing
12.4.1 Transdermal Patch Sales Channels
12.4.2 Transdermal Patch Distributors
12.5 Transdermal Patch Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Transdermal Patch Industry Trends
13.2 Transdermal Patch Market Drivers
13.3 Transdermal Patch Market Challenges
13.4 Transdermal Patch Market Restraints
14 Key Findings in The Global Transdermal Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Transdermal Patch Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Methyl Salicylate-based Patch
Table 3. Major Manufacturers of Rivastigmine Transdermal Patch
Table 4. Major Manufacturers of Fentanyl Transdermal Patch
Table 5. Major Manufacturers of Lidocaine Patch
Table 6. Major Manufacturers of Diclofenac Patch
Table 7. Major Manufacturers of Nicotine Transdermal Patch
Table 8. Major Manufacturers of Others
Table 9. Global Transdermal Patch Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 10. Global Transdermal Patch Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Transdermal Patch Sales by Region (2016-2021) & (M Pcs)
Table 12. Global Transdermal Patch Sales Market Share by Region (2016-2021)
Table 13. Global Transdermal Patch Sales by Region (2016-2021) & (M Pcs)
Table 14. Global Transdermal Patch Sales Market Share by Region (2022-2027)
Table 15. Global Transdermal Patch Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Transdermal Patch Revenue Market Share by Region (2016-2021)
Table 17. Global Transdermal Patch Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Transdermal Patch Revenue Market Share by Region (2022-2027)
Table 19. Global Transdermal Patch Sales by Manufacturers (2016-2021) & (M Pcs)
Table 20. Global Transdermal Patch Sales Share by Manufacturers (2016-2021)
Table 21. Global Transdermal Patch Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 22. Global Transdermal Patch Revenue Share by Manufacturers (2016-2021)
Table 23. Transdermal Patch Price by Manufacturers 2016-2021 (USD/Pc)
Table 24. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2020)
Table 26. Transdermal Patch Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Transdermal Patch Product Offered
Table 28. Date of Manufacturers Enter into Transdermal Patch Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 31. Global Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 32. Global Transdermal Patch Sales Share by Type (2016-2021)
Table 33. Global Transdermal Patch Sales Share by Type (2022-2027)
Table 34. Global Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 35. Global Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 36. Global Transdermal Patch Revenue Share by Type (2016-2021)
Table 37. Global Transdermal Patch Revenue Share by Type (2022-2027)
Table 38. Transdermal Patch Price by Type (2016-2021) & (USD/Pc)
Table 39. Global Transdermal Patch Price Forecast by Type (2022-2027) & (USD/Pc)
Table 40. Global Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 41. Global Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 42. Global Transdermal Patch Sales Share by Application (2016-2021)
Table 43. Global Transdermal Patch Sales Share by Application (2022-2027)
Table 44. Global Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 45. Global Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 46. Global Transdermal Patch Revenue Share by Application (2016-2021)
Table 47. Global Transdermal Patch Revenue Share by Application (2022-2027)
Table 48. Transdermal Patch Price by Application (2016-2021) & (USD/Pc)
Table 49. Global Transdermal Patch Price Forecast by Application (2022-2027) & (USD/Pc)
Table 50. North America Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 51. North America Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 52. North America Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 53. North America Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 54. North America Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 55. North America Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 56. North America Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 57. North America Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 58. North America Transdermal Patch Sales by Country (2016-2021) & (M Pcs)
Table 59. North America Transdermal Patch Sales by Country (2022-2027) & (M Pcs)
Table 60. North America Transdermal Patch Revenue by Country (2016-2021) & (US$ Million)
Table 61. North America Transdermal Patch Revenue by Country (2022-2027) & (US$ Million)
Table 62. Europe Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 63. Europe Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 64. Europe Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 65. Europe Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 66. Europe Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 67. Europe Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 68. Europe Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 69. Europe Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 70. Europe Transdermal Patch Sales by Country (2016-2021) & (M Pcs)
Table 71. Europe Transdermal Patch Sales by Country (2022-2027) & (M Pcs)
Table 72. Europe Transdermal Patch Revenue by Country (2016-2021) & (US$ Million)
Table 73. Europe Transdermal Patch Revenue by Country (2022-2027) & (US$ Million)
Table 74. Asia Pacific Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 75. Asia Pacific Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 76. Asia Pacific Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 77. Asia Pacific Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 78. Asia Pacific Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 79. Asia Pacific Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 80. Asia Pacific Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 81. Asia Pacific Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 82. Asia Pacific Transdermal Patch Sales by Region (2016-2021) & (M Pcs)
Table 83. Asia Pacific Transdermal Patch Sales by Region (2022-2027) & (M Pcs)
Table 84. Asia Pacific Transdermal Patch Revenue by Region (2016-2021) & (US$ Million)
Table 85. Asia Pacific Transdermal Patch Revenue by Region (2022-2027) & (US$ Million)
Table 86. Latin America Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 87. Latin America Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 88. Latin America Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 89. Latin America Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 90. Latin America Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 91. Latin America Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 92. Latin America Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 93. Latin America Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 94. Latin America Transdermal Patch Sales by Country (2016-2021) & (M Pcs)
Table 95. Latin America Transdermal Patch Sales by Country (2022-2027) & (M Pcs)
Table 96. Latin America Transdermal Patch Revenue by Country (2016-2021) & (US$ Million)
Table 97. Latin America Transdermal Patch Revenue by Country (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Transdermal Patch Sales by Type (2016-2021) & (M Pcs)
Table 99. Middle East and Africa Transdermal Patch Sales by Type (2022-2027) & (M Pcs)
Table 100. Middle East and Africa Transdermal Patch Revenue by Type (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Transdermal Patch Revenue by Type (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Transdermal Patch Sales by Application (2016-2021) & (M Pcs)
Table 103. Middle East and Africa Transdermal Patch Sales by Application (2022-2027) & (M Pcs)
Table 104. Middle East and Africa Transdermal Patch Revenue by Application (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Transdermal Patch Revenue by Application (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Transdermal Patch Sales by Country (2016-2021) & (M Pcs)
Table 107. Middle East and Africa Transdermal Patch Sales by Country (2022-2027) & (M Pcs)
Table 108. Middle East and Africa Transdermal Patch Revenue by Country (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Transdermal Patch Revenue by Country (2022-2027) & (US$ Million)
Table 110. Hisamitsu Pharmaceutical Corporation Information
Table 111. Hisamitsu Pharmaceutical Description and Major Businesses
Table 112. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 113. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 114. Hisamitsu Pharmaceutical Recent Developments
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Major Businesses
Table 117. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Transdermal Patch Product
Table 119. Johnson & Johnson Recent Developments
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Major Businesses
Table 122. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 123. Novartis Transdermal Patch Product
Table 124. Novartis Recent Developments
Table 125. UCB Pharma Corporation Information
Table 126. UCB Pharma Description and Major Businesses
Table 127. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 128. UCB Pharma Transdermal Patch Product
Table 129. UCB Pharma Recent Developments
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Major Businesses
Table 132. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 133. Mylan Transdermal Patch Product
Table 134. Mylan Recent Developments
Table 135. Teva Pharmaceutical Corporation Information
Table 136. Teva Pharmaceutical Description and Major Businesses
Table 137. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 138. Teva Pharmaceutical Transdermal Patch Product
Table 139. Teva Pharmaceutical Recent Developments
Table 140. Nitto Denko Corporation Information
Table 141. Nitto Denko Description and Major Businesses
Table 142. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 143. Nitto Denko Transdermal Patch Product
Table 144. Nitto Denko Recent Developments
Table 145. Grünenthal Corporation Information
Table 146. Grünenthal Description and Major Businesses
Table 147. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 148. Grünenthal Transdermal Patch Product
Table 149. Grünenthal Recent Developments
Table 150. IBSA Group Corporation Information
Table 151. IBSA Group Description and Major Businesses
Table 152. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 153. IBSA Group Transdermal Patch Product
Table 154. IBSA Group Recent Developments
Table 155. GSK Corporation Information
Table 156. GSK Description and Major Businesses
Table 157. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 158. GSK Transdermal Patch Product
Table 159. GSK Recent Developments
Table 160. Luye Pharma Group Corporation Information
Table 161. Luye Pharma Group Description and Major Businesses
Table 162. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 163. Luye Pharma Group Transdermal Patch Product
Table 164. Luye Pharma Group Recent Developments
Table 165. Pfizer Corporation Information
Table 166. Pfizer Description and Major Businesses
Table 167. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 168. Pfizer Transdermal Patch Product
Table 169. Pfizer Recent Developments
Table 170. Chattem Corporation Information
Table 171. Chattem Description and Major Businesses
Table 172. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 173. Chattem Transdermal Patch Product
Table 174. Chattem Recent Developments
Table 175. Dr Reddy's Laboratories Corporation Information
Table 176. Dr Reddy's Laboratories Description and Major Businesses
Table 177. Dr Reddy's Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 178. Dr Reddy's Laboratories Transdermal Patch Product
Table 179. Dr Reddy's Laboratories Recent Developments
Table 180. Bayer Corporation Information
Table 181. Bayer Description and Major Businesses
Table 182. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 183. Bayer Transdermal Patch Product
Table 184. Bayer Recent Developments
Table 185. Mundipharma Corporation Information
Table 186. Mundipharma Description and Major Businesses
Table 187. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 188. Mundipharma Transdermal Patch Product
Table 189. Mundipharma Recent Developments
Table 190. Endo International Corporation Information
Table 191. Endo International Description and Major Businesses
Table 192. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 193. Endo International Transdermal Patch Product
Table 194. Endo International Recent Developments
Table 195. Beijing Tide Pharmaceutical Corporation Information
Table 196. Beijing Tide Pharmaceutical Description and Major Businesses
Table 197. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2016-2021)
Table 198. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 199. Beijing Tide Pharmaceutical Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Transdermal Patch Distributors List
Table 203. Transdermal Patch Customers List
Table 204. Transdermal Patch Market Trends
Table 205. Transdermal Patch Market Drivers
Table 206. Transdermal Patch Market Challenges
Table 207. Transdermal Patch Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of FiguresFigure 1. Transdermal Patch Product Picture
Figure 2. Global Transdermal Patch Market Share by Type in 2020 & 2027
Figure 3. Methyl Salicylate-based Patch Product Picture
Figure 4. Rivastigmine Transdermal Patch Product Picture
Figure 5. Fentanyl Transdermal Patch Product Picture
Figure 6. Lidocaine Patch Product Picture
Figure 7. Diclofenac Patch Product Picture
Figure 8. Nicotine Transdermal Patch Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transdermal Patch Sales Market Share by Application in 2020 & 2027
Figure 11. Rx Channel
Figure 12. OTC Channel
Figure 13. Transdermal Patch Report Years Considered
Figure 14. Global Transdermal Patch Sales 2016-2027 (M Pcs)
Figure 15. Global Transdermal Patch Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Transdermal Patch Revenue 2016-2027 (US$ Million)
Figure 17. Global Transdermal Patch Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global Transdermal Patch Sales Market Share by Region (2016-2021)
Figure 19. Global Transdermal Patch Sales Market Share by Region (2022-2027)
Figure 20. North America Transdermal Patch Sales YoY (2016-2027) & (M Pcs)
Figure 21. North America Transdermal Patch Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe Transdermal Patch Sales YoY (2016-2027) & (M Pcs)
Figure 23. Europe Transdermal Patch Revenue YoY (2016-2027) &